Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc., 11558 [2021-03837]

Download as PDF 11558 Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.33(a), this is notice that on July 20, 2020, Chattem Chemicals 3801 Saint Elmo Avenue, Chattanooga, Tennessee 37409, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Drug code Gamma Hydroxybutyric Acid .... Marihuana ................................. Tetrahydrocannabinols ............. 4-Methoxyamphetamine ........... Dihydromorphine ....................... Norlevorphanol .......................... Amphetamine ............................ Methamphetamine .................... Lisdexamfetamine ..................... Methylphenidate ........................ ANPP (4-Anilino-N-phenethyl-4piperidine). Phenylacetone .......................... Cocaine ..................................... Codeine ..................................... Dihydrocodeine ......................... Oxycodone ................................ Hydromorphone ........................ Hydrocodone ............................. Levorphanol .............................. Meperidine ................................ Meperidine intermediate–A ....... Meperidine intermediate–B ....... Meperidine intermediate–C ....... Methadone ................................ Methadone intermediate ........... Morphine ................................... Oripavine ................................... Thebaine ................................... Opium, powdered ..................... Opium, granulated .................... Oxymorphone ........................... Noroxymorphone ...................... Racemethorphan ...................... Alfentanil ................................... Remifentanil .............................. Sufentanil .................................. Tapentadol ................................ Fentanyl .................................... Schedule 2010 7360 7370 7411 9145 9634 1100 1105 1205 1724 8333 I I I I I I II II II II II 8501 9041 9050 9120 9143 9150 9193 9220 9230 9232 9233 9234 9250 9254 9300 9330 9333 9639 9640 9652 9668 9732 9737 9739 9740 9780 9801 II II II II II II II II II II II II II II II II II II II II II II II II II II II [FR Doc. 2021–03836 Filed 2–24–21; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 17:04 Feb 24, 2021 Jkt 253001 Drug Enforcement Administration [Docket No. DEA–791] Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc. Drug Enforcement Administration, Justice. AGENCY: ACTION: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on November 11, 2020, S&B Pharma, Inc., 405 South Motor Avenue, Azusa, California 91702–3232, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Gamma Hydroxybutyric Acid .... Tetrahydrocannabinols ............. Amphetamine ............................ Methamphetamine .................... Lisdexamfetamine ..................... Methylphenidate ........................ Pentobarbital ............................. 4-Anilino-N-phenethyl-4-piperidine (ANPP). Tapentadol ................................ Fentanyl .................................... Drug code Schedule 7360 7370 1100 1105 1205 1724 2270 8333 I I II II II II II II 9780 9801 II II The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers. In reference to drug code 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture both as synthetic substances. No other Frm 00064 Fmt 4703 DEPARTMENT OF JUSTICE [Docket No. DEA798] Notice of application. Controlled substance BILLING CODE 4410–09–P Drug Enforcement Administration S&B Pharma, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. PO 00000 William T. McDermott, Assistant Administrator. [FR Doc. 2021–03837 Filed 2–24–21; 8:45 am] SUMMARY: The company plans to manufacturer the listed controlled substances in bulk for distribution and sale to its customers. In reference to drug code 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as a synthetic. No other activities for this drug code are authorized for this registration. William T. McDermott, Assistant Administrator. activity for these drug codes is authorized for this registration. DEPARTMENT OF JUSTICE Sfmt 4703 Importer of Controlled Substances Application: Myonex Inc Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Myonex Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 29, 2021. Such persons may also file a written request for a hearing on the application on or before March 29, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on January 6, 2021, Myonex Inc, 48 East Main Street, Norristown, Pennsylvania 19401–4915, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DATES: Controlled substance Amphetamine ................. Lisdexamfetamine .......... Methylphenidate ............. E:\FR\FM\25FEN1.SGM 25FEN1 Drug code Schedule 1100 1205 1724 II II II

Agencies

[Federal Register Volume 86, Number 36 (Thursday, February 25, 2021)]
[Notices]
[Page 11558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03837]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-791]


Bulk Manufacturer of Controlled Substances Application: S&B 
Pharma, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: S&B Pharma, Inc., has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 11, 2020, S&B Pharma, Inc., 405 South Motor 
Avenue, Azusa, California 91702-3232, applied to be registered as an 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............    7360  I
Tetrahydrocannabinols...................    7370  I
Amphetamine.............................    1100  II
Methamphetamine.........................    1105  II
Lisdexamfetamine........................    1205  II
Methylphenidate.........................    1724  II
Pentobarbital...........................    2270  II
4-Anilino-N-phenethyl-4-piperidine          8333  II
 (ANPP).
Tapentadol..............................    9780  II
Fentanyl................................    9801  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for use in product development and for commercial sales to its 
customers. In reference to drug code 7360 (Marihuana) and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture both as 
synthetic substances. No other activity for these drug codes is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03837 Filed 2-24-21; 8:45 am]
BILLING CODE 4410-09-P